Results 161 to 170 of about 1,415,651 (391)
Treatment of Asthma and Associated Diseases in Children [PDF]
, 1922 Allan R. Cunningham
openalex +1 more source
Wearable Biomonitoring with 2D Carbon‐Based Nanocomposite Hydrogels
Advanced Physics Research, EarlyView.This review critically examines recent advancements in nanocomposite hydrogels, emphasizing the reinforcement mechanisms offered by 2D carbon‐based nanomaterials and exploring the various applications of these hydrogels. Furthermore, it discusses the current challenges and potential avenues for future development and practical implementation of ...
Ning Li +6 more
wiley +1 more source
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
European Respiratory Journal, 2013 K. Chung +22 more
semanticscholar +1 more source
The Anatomical Record, EarlyView.Abstract Autonomic nerves are crucial in cardiac function and pathology. However, data on the distribution of cholinergic and noradrenergic nerves in normal and pathologic human hearts is lacking. Nonfailing donor hearts were pressure‐perfusion fixed, imaged, and dissected. Left ventricular cardiomyopathy samples were also obtained.
Peter Hanna +15 more
wiley +1 more source
Die Wirkung des erhöhten Luftdrucks in den pneumatischen Kammern bei Asthma1) [PDF]
, 1885 G. Liebig
openalex +1 more source
Arthritis &Rheumatology, EarlyView.Objective The aim of this study was to determine whether pollutants such as fire smoke–related particulate matter <2.5 μm (PM2.5) are associated with incident rheumatoid arthritis (RA) and RA‐associated interstitial lung disease (RA‐ILD). Methods This patient–control study used Veterans Affairs (VA) data from October 1, 2009, to December 31, 2018.
Vanessa L. Kronzer +13 more
wiley +1 more source
The global burden of asthma: executive summary of the GINA Dissemination Committee Report
Allergy. European Journal of Allergy and Clinical Immunology, 2004 M. Masoli +3 more
semanticscholar +1 more source
Long‐Term Safety and Efficacy of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis
Arthritis &Rheumatology, EarlyView.Objective Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare, relapsing, inflammatory disease. Management of EGPA predominantly relies on oral corticosteroids (OCS), which are associated with many adverse effects. The phase 3 MIRRA trial demonstrated efficacy and safety of mepolizumab, anti‐interleukin‐5 biologic, for EGPA.
Michael E. Wechsler +34 more
wiley +1 more source